Preview Mode Links will not work in preview mode

Mar 8, 2024

Featuring perspectives from Dr Stephen T Oh, including the following topics:

  • Introduction: ASH 2023 Update (0:00)
  •  Case: A woman in her early 70s with symptomatic primary myelofibrosis (MF) receives ruxolitinib — Rao Mushtaq, MD (15:41)
  • Case: A woman in her late 60s, a Jehovah’s Witness with multiple comorbidities,...


Feb 27, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Chronic Lymphocytic Leukemia | Faculty Presentation 1: Current Management Approaches for Patients with Chronic Lymphocytic Leukemia (CLL) — Jeff Sharman, MD  

CME information and select publications


Feb 27, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Chronic Lymphocytic Leukemia | Faculty Presentation 2: Future Directions in the Care of Patients with CLL — Lindsey Roeker, MD

CME information and select...


Feb 27, 2024

Featuring perspectives from Dr Lindsey Roeker and Dr Jeff Sharman, including the following topics:

  • An Audio Depiction of Mechanisms of Action of Bcl-2 Inhibitors, Anti-CD20 Antibodies and Covalent and Noncovalent Bruton Tyrosine Kinase Inhibitors; Mechanisms of Resistance (0:00)
  • Current Management Approaches for...


Jan 17, 2024

Featuring perspectives from Dr Richard M Stone, including the following topics: 
• Introduction: ASH 2023 Update — Key Oral Presentations (0:00)
• Case: A woman in her early 90s with dementia who presented with anemia and was diagnosed with low-risk myelodysplastic syndromes (MDS) with ring sideroblasts, now...